Saudi Arabia at a glance
- Population
- 37.0 million 2025
- Life expectancy at birth
- 79.0 years, 2024
- People aged 65 and over
- 3.1 % of people, 2025
- Health spending per person
- 1,825 US$ per person, 2023
- Doctors
- 3.41 per 1,000 people, 2023
Updated
Reviewed by Chandani Patel
Saudi Arabia Glaucoma Surgery Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Procedure, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$32.9 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $20.8 Mn | — | — |
| 2025 (base) | $22.9 Mn | +$2.2 Mn | — |
| 2026 (forecast) | $25.3 Mn | +$2.4 Mn | +10.4% |
| 2027 (forecast) | $27.9 Mn | +$2.6 Mn | +21.9% |
| 2028 (forecast) | $30.8 Mn | +$2.9 Mn | +34.6% |
| 2029 (forecast) | $34.0 Mn | +$3.2 Mn | +48.6% |
| 2030 (forecast) | $37.6 Mn | +$3.5 Mn | +64% |
| 2031 (forecast) | $41.5 Mn | +$3.9 Mn | +81.1% |
| 2032 (forecast) | $45.8 Mn | +$4.3 Mn | +99.9% |
| 2033 (forecast) | $50.6 Mn | +$4.8 Mn | +120.7% |
| 2034 (forecast) | $55.8 Mn | +$5.3 Mn | +143.6% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $22.9 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $55.8 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 10.4% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, procedure and end user (see all) |
| Key players | Glaukos, Alcon, Johnson & Johnson, Sight Sciences, Ellex (Lumibird) (see all) |
| Regulator in Saudi Arabia | SFDASource: Saudi Food and Drug Authority. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Glaucoma surgery devices lower eye pressure using tiny stents, shunts and lasers, often during cataract surgery.
Key segments of the glaucoma Surgery Devices market include product (MIGS Devices, Glaucoma Drainage Devices and Laser Systems) and procedure (Standalone and Combined with Cataract Surgery).
An ageing population, more people with diabetes and long-term conditions, better treatments and wider access to specialist care are driving the glaucoma Surgery Devices market.
Longer-acting treatments, home-based care and screening in emerging markets give the glaucoma Surgery Devices market room to grow.
High costs of new treatments, specialist shortages, low awareness and limited reimbursement in some countries hold back the glaucoma Surgery Devices market.
The glaucoma Surgery Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices need marketing authorisation from the Saudi Food and Drug Authority (SFDA).[1] Citizens get free public care through the Ministry of Health, while most expatriate workers must have private health insurance, regulated by the Council of Health Insurance (CHI).[2]
[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.
[2] Council of Health Insurance. Checked 14 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how glaucoma Surgery Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Saudi Arabia.
What doctors and scientists are doing in Glaucoma Surgery Devices right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.
Saudi Arabia · 1 shared keyword
Saudi Arabia · 1 shared keyword
Saudi Arabia
Saudi Arabia
Saudi Arabia
Saudi Arabia
Digital Health · Saudi Arabia
Pharmaceuticals · Saudi Arabia
Public Health · Saudi Arabia
Pharmaceuticals · Saudi Arabia
OTC & Nutraceuticals · Saudi Arabia
Pharmaceuticals · Saudi Arabia